Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of unreliable AI in high-stakes roles.

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

“If the question is, can AI replace a human reviewer, I would say absolutely not,” said Jason Conaty, counsel in the Los Angeles office of Hogan Lovells who specializes in drug regulatory affairs.

"As we learn those molecular signatures across diverse populations, we can understand their unique biology," Curtis said. Continue on to Part 2 and Part 3of AI's Drug Revolution.

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested and a growing aging population, most drug candidates have failed during ...

The U.S. Food and Drug Administration (FDA) has introduced “Elsa,” a generative AI tool designed to enhance the efficiency of its regulatory operations.